AKT1 and Alzheimer disease: It can combine cell-derived exosomes by activating the Protein kinase B/Glycogen synthase kinase-3 (AKT/GSK-3β) pathway to inhibit phosphorylation of the tau protein, which prevents neuronal death and relieves AD symptoms in vivo (119).